SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc.
MNTA 52.480.0%Oct 2 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: idos who wrote (2871)11/28/2011 12:03:29 PM
From: tuck  Read Replies (2) of 3027
 
Amphastar's request for the stay of the preliminary injunction is denied, and the order reveals Sanofi has suspended sales of the AG, after selling some "at a substantial discount" to a couple of large customers (CVS and McKesson). All we need now is Sandoz agreeing to return the non-AG profit split. Amphastar had better hope so, too, as it could be on the hook for damages related to the differential, estimated at ~$30 million annually, pre-tax, if not.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News